Articles: function.
-
Interstitial Lung Disease CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMINTRODUCTION: A Niemann-Pick disease is caused by sphingomyelinase deficiency resulting in the accumulation of sphingomyelin in various cell types. Prognosis varies in accordance with organ involvement. The case presented relates to subtype B, characterized by visceral involvement and no neurological deficit. ⋯ The following authors have nothing to disclose: Ines Sanches, Cidália Rodrigues, Fátima Teixeira, Yvette MartinsNo Product/Research Disclosure Information.
-
Pulmonary Function TestingSESSION TYPE: Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: Exhaled nitric oxide (FeNO) and Methacholine challenge (MCH) are both utilized in the detection and management of numerous pulmonary diseases. MCH is a measure of direct airway hyperresponsiveness. FeNO measures bronchial epithelial damage from eosinophilic bronchitis whether asthma or non-asthma related. FeNO has an attractive performance profile, as it is a cheaper and less invasive test. We hypothesize that FeNO can decrease the need for MCH testing. ⋯ The following authors have nothing to disclose: Andrew Nickels, Kenneth Parker, Paul Scanlon, Kaiser LimNo Product/Research Disclosure Information.
-
Surgery Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: We report a patient in whom pleuroperitoneal communication was diagnosed following the initiation of peritoneal dialysis (PD), in whom the PD could be continued after thoracoscopic partial resection of the diaphragm. ⋯ The following authors have nothing to disclose: Ryo Takahashi, Yuuichirou TakahashiNo Product/Research Disclosure Information.
-
BronchiectasisSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Evaluation of morbidity and risk factors for mortality in hospitalized patients with acute exacerbation of bronchiectasis. ⋯ The following authors have nothing to disclose: Maria João Oliveira, Daniel Vaz, Daniel Coutinho, Margarida Dias, Maria do Céu BritoNo Product/Research Disclosure Information.
-
Infectious Disease Case Reports Posters IIISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Mycobacterium celatum was first described in 1993 and since then , sporadic reports have been published on the isolation of this mycobacterium from immunocomprised pateints. M. celatum is phenotypically similar to M. avium and M. xenopi. M. celatum is a recently described organism. Several reports exist in the literature establishing this organism as a convincing pathogen among Human Immunodeficiency Virus (HIV) seropositive patients. However, there is now evidence of its pathogenicity among individuals whose immune function is not profoundly impaired. ⋯ The following authors have nothing to disclose: Abdulrahman HakamiNo Product/Research Disclosure Information.